Pandemic Preparedness: Accelerating Vaccine Development in a Pandemic
For the last decade, Sartorius has collaborated with biopharmaceutical companies to help manufacture vaccines for infectious disease outbreaks and pandemics like Ebola, Zika, and H1N1. The COVID-19 pandemic has allowed us to build on this foundation — and learn even more about pandemic preparedness.
We learned the importance of dedicated partnerships among various industry stakeholders. We also learned that disruptive technologies, such as mRNA vaccines, are essential to respond with agility — and to deliver life-saving vaccines today and beyond.
Sartorius stands ready to help our customers reimagine their businesses — so they can, in turn, deliver the next generation of life-saving vaccines.
Contact a Vaccine Specialist
Our vaccine experts Amélie Boulais and Piergiuseppe Nestola talk about trending topics around COVID-19 and what to consider for future pandemics.
Part 1 – The Need for Speed and SafetyPart 2 – Regulatory ConsiderationsPart 3 – Vaccine ModalitiesPart 4 – Commercial ManufacturingPart 5 – Reducing CostsPart 6 – Logistics and Global AvailabilityPart 7 – Progress Over TimePart 8 – Lessons to Be Learned
Download eBook
Preparing for the next pandemic will take multiple vaccine platforms, including traditional and emerging technologies. Our interactive process flow diagrams allow you to explore the challenges, and Sartorius’ solutions, for:
Explore Our Vaccine Development Portfolio
The industry’s response to the COVID-19 pandemic proved the importance of collaboration to reimagine vaccine development. Sartorius can help you:
mRNA vaccines are positioned to revolutionize the industry, simplifying development and increasing manufacturing speed. Our vaccine specialists can help you:
The industry must increase its agility and flexibility if we are to be prepared for the next pandemic.
Sartorius has collaborated with industry participants to develop and manufacture COVID-19 vaccines. There are many lessons from this process, and our team of experts share their knowledge and insights in a variety of resources. Prepare for the next pandemic with Sartorius at your side — learn from our experts and feel free to contact us to engage in further discussions.
Download Infographic
Sartorius has presented its capacity to support the industry to develop and manufacture a COVID-19 vaccine in a series of webinars. From processes overviews to deep dives into specific technologies and Services, listen to our experts and feel free to contact us to engage in further discussions.
The webinar will outline the use of Sartobind® membrane chromatography for the purification of virus-based biologics also linking to the current COVID...
Fast Development of Coronavirus Vaccines
Accelerate Vaccine Development With Rapid Total Particle Quantification
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.